October 02, 2022
2 min watch
Packer M. Safety and effectiveness of a new FDA-approved dispersive ophthalmic viscosurgical device. Presented at: American Academy of Ophthalmology meeting; Sept. 30-Oct. 3, 2022; Chicago.
Packer reports consulting for Bausch + Lomb and other members of the ophthalmic industrial community.
CHICAGO — In this Healio Video Perspective from the AAO meeting, Mark Packer, MD, discusses the effectiveness of ClearVisc, a new dispersive ophthalmic viscosurgical device from Bausch + Lomb.
“Here we have a new tool in our armamentarium for cataract surgery, a brand-new ophthalmic dispersive viscoelastic, which we can use to help protect the cornea and give our patients better vision on postop day 1,” he said.